CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-11 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +4,153 | $17.93 | $74K | 2,568,706 |
| 2015-12-18 | Walker Neal President and CEO | Grant or award · Stock option (right to buy) | +137,335 | 137,335 | ||
| 2015-12-18 | Walker Neal President and CEO | Grant or award · Restricted stock units | +11,700 | 11,700 | ||
| 2015-12-18 | Tullman Stephen A. Director | Grant or award · Stock option (right to buy) | +7,095 | 7,095 | ||
| 2015-12-18 | Shanler Stuart Chief Scientific Officer | Grant or award · Stock option (right to buy) | +53,833 | 53,833 | ||
| 2015-12-18 | Shanler Stuart Chief Scientific Officer | Grant or award · Restricted stock units | +5,800 | 5,800 | ||
| 2015-12-18 | Ruffo Frank Chief Financial Officer | Grant or award · Stock option (right to buy) | +49,439 | 49,439 | ||
| 2015-12-18 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +5,000 | 5,000 | ||
| 2015-12-18 | Powala Christopher Chief Operating Officer | Grant or award · Stock option (right to buy) | +58,516 | 58,516 | ||
| 2015-12-18 | Powala Christopher Chief Operating Officer | Grant or award · Restricted stock units | +6,500 | 6,500 | ||
| 2015-12-18 | Molineaux Christopher P. Director | Grant or award · Stock option (right to buy) | +2,759 | 2,759 | ||
| 2015-12-18 | Ali-Jackson Kamil Chief Legal Officer | Grant or award · Stock option (right to buy) | +45,939 | 45,939 | ||
| 2015-12-18 | Ali-Jackson Kamil Chief Legal Officer | Grant or award · Restricted stock units | +4,300 | 4,300 | ||
| 2015-10-29 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +95,000 | $14.00 | $1.3M | 2,564,552 |
| 2015-10-28 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +149,200 | $14.00 | $2.1M | 2,469,552 |
| 2015-10-22 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +5,410 | $14.03 | $76K | 2,320,352 |
| 2015-10-21 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +3,100 | $14.83 | $46K | 2,314,942 |
| 2015-10-20 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +7,965 | $14.95 | $119K | 2,311,842 |
| 2015-10-19 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +23,934 | $14.88 | $356K | 2,303,877 |
| 2015-10-14 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +42,813 | $14.06 | $602K | 2,279,943 |
Page 54 of 57 · 1,130 trades